A

OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143

Neuro-Oncology

Authors 0

  1. Author list not loaded yet.

Cited by 1 stored of 330

1 result

References 0